117 related articles for article (PubMed ID: 15192121)
1. Nucleosomes bind fibroblast growth factor-2 for increased angiogenesis in vitro and in vivo.
Tanner JE; Forté A; Panchal C
Mol Cancer Res; 2004 May; 2(5):281-8. PubMed ID: 15192121
[TBL] [Abstract][Full Text] [Related]
2. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
[TBL] [Abstract][Full Text] [Related]
4. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
5. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
8. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M
Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311
[TBL] [Abstract][Full Text] [Related]
10. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
11. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
12. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
Li J; Huang S; Armstrong EA; Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810
[TBL] [Abstract][Full Text] [Related]
14. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
15. Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2.
Tepper OM; Callaghan MJ; Chang EI; Galiano RD; Bhatt KA; Baharestani S; Gan J; Simon B; Hopper RA; Levine JP; Gurtner GC
FASEB J; 2004 Aug; 18(11):1231-3. PubMed ID: 15208265
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.
Olsen MW; Ley CD; Junker N; Hansen AJ; Lund EL; Kristjansen PE
Neoplasia; 2006 May; 8(5):364-72. PubMed ID: 16790085
[TBL] [Abstract][Full Text] [Related]
18. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
20. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]